A Phase II Multi-Institutional Trial of Focal Radiotherapy with Concomitant Carboplatin as a Radiosensitizer and the Prospective Analysis of Survivin an Inhibitor of Apoptosis as a Biomarker in Children with Newly Diagnosed Non-Metastatic Ependymoma and Minimal Residual Disease Post-Operatively
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is designed to find out whether carboplatin (a chemotherapy drug), which is thought to increase the effect of the radiation therapy, can be safely given at the same time as focal radiation therapy (radiation delivered only to the tumor).
Description
This study is designed to find out whether carboplatin (a chemotherapy drug), which is thought to increase the effect of the radiation therapy, can be safely given at the same time as focal radiation therapy (radiation delivered only to the tumor).
Details
| Condition | Brain Cancer |
|---|---|
| Age | 1years - 21years |
| Clinical Study Identifier | TX3765 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.